Abstract
Connective tissue diseases (CTD) encompass a range of heritable and autoimmune conditions that are well known for their systemic effects. While these conditions have been observed to impact the lung in myriad fashion, bronchiectasis remains an often overlooked pulmonary complication, despite the fact that the prevalence of bronchiectasis can be as high as 60 % in patients with rheumatoid arthritis. In this review, we cover the epidemiology and clinical findings of bronchiectasis in autoimmune CTDs such as rheumatoid arthritis and Sjögren’s syndrome and heritable CTDs such as Marfan syndrome and Ehlers-Danlos syndrome. We propose that changes in the oral, gut, and lung microbiome may influence autoimmunity and the structural integrity of the airway, thus leading to bronchiectasis.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Fournier A, Cockenpot F. Syndrome d’Ehlers-Danlos; dilatation des bronches; retard staturo-ponderal. J Sci Med Lille. 1949;67(6):92–6.
Young A, Koduri G, Batley M, Kulinskaya E, Gough A, Norton S, et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford). 2007;46(2):350–7.
Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972–2002. Ann Rheum Dis. 2007;66(7):940–4.
Fisher MR, Mathai SC, Champion HC, Girgis RE, Housten-Harris T, Hummers L, et al. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum. 2006;54(9):3043–50.
Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, et al. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011;63(3):633–9.
Baggenstoss AH, Rosenberg EF. Visceral lesions associated with chronic infectious (rheumatoid) arthritis. Arch Path. 1943;35:503.
Bach F. Penicillin for the rheumatoid type of arthritis. Ann Rheum Dis. 1948;7(1):25–7.
Aronoff A, Bywaters EG, Fearnley GR. Lung lesions in rheumatoid arthritis. Br Med J. 1955;2(4933):228–32.
Solanki T, Neville E. Bronchiectasis and rheumatoid disease: is there an association? Br J Rheumatol. 1992;31(10):691–3.
Brannan HM, Good CA, Divertie MB, Baggenstoss AH. Pulmonary disease associated with rheumatoid arthritis. JAMA. 1964;189:914–8.
Stack BH, Grant IW. Rheumatoid interstitial lung disease. Br J Dis Chest. 1965;59(4):202–11.
Walker WC. Pulmonary infections and rheumatoid arthritis. Q J Med. 1967;36(142):239–51.
McDonagh J, Greaves M, Wright AR, Heycock C, Owen JP, Kelly C. High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease. Br J Rheumatol. 1994;33(2):118–22.
Remy-Jardin M, Remy J, Cortet B, Mauri F, Delcambre B. Lung changes in rheumatoid arthritis: CT findings. Radiology. 1994;193(2):375–82.
Demir R, Bodur H, Tokoglu F, Olcay I, Ucan H, Borman P. High resolution computed tomography of the lungs in patients with rheumatoid arthritis. Rheumatol Int. 1999;19(1–2):19–22.
Cortet B, Perez T, Roux N, Flipo RM, Duquesnoy B, Delcambre B, et al. Pulmonary function tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis. Ann Rheum Dis. 1997;56(10):596–600.
Cortet B, Flipo RM, Remy-Jardin M, Coquerelle P, Duquesnoy B, Remy J, et al. Use of high resolution computed tomography of the lungs in patients with rheumatoid arthritis. Ann Rheum Dis. 1995;54(10):815–9.
Hassan WU, Keaney NP, Holland CD, Kelly CA. High resolution computed tomography of the lung in lifelong non-smoking patients with rheumatoid arthritis. Ann Rheum Dis. 1995;54(4):308–10.
Despaux J, Manzoni P, Toussirot E, Auge B, Cedoz JP, Wendling D. Prospective study of the prevalence of bronchiectasis in rheumatoid arthritis using high-resolution computed tomography. Rev Rhum Engl Ed. 1998;65(7–9):453–61.
Perez T, Remy-Jardin M, Cortet B. Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1658–65.
Izumiyama T, Hama H, Miura M, Hatakeyama A, Suzuki Y, Sawai T, et al. Frequency of broncho-bronchiolar disease in rheumatoid arthritis: an examination by high-resolution computed tomography. Mod Rheumatol / Jpn Rheum Assoc. 2002;12(4):311–7.
Bilgici A, Ulusoy H, Kuru O, Celenk C, Unsal M, Danaci M. Pulmonary involvement in rheumatoid arthritis. Rheumatol Int. 2005;25(6):429–35.
Zrour SH, Touzi M, Bejia I, Golli M, Rouatbi N, Sakly N, et al. Correlations between high-resolution computed tomography of the chest and clinical function in patients with rheumatoid arthritis. Prospective study in 75 patients. Joint Bone Spine. 2005;72(1):41–7.
Metafratzi ZM, Georgiadis AN, Ioannidou CV, Alamanos Y, Vassiliou MP, Zikou AK, et al. Pulmonary involvement in patients with early rheumatoid arthritis. Scand J Rheumatol. 2007;36(5):338–44.
Mohd Noor N, Mohd Shahrir MS, Shahid MS, Abdul Manap R, Shahizon Azura AM, Azhar SS. Clinical and high resolution computed tomography characteristics of patients with rheumatoid arthritis lung disease. Int J Rheum Dis. 2009;12(2):136–44.
Tsuchiya Y, Takayanagi N, Sugiura H, Miyahara Y, Tokunaga D, Kawabata Y, et al. Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Eur Respir J. 2011;37(6):1411–7.
Wilsher M, Voight L, Milne D, Teh M, Good N, Kolbe J, et al. Prevalence of airway and parenchymal abnormalities in newly diagnosed rheumatoid arthritis. Respir Med. 2012;106(10):1441–6.
Koch MC, Pereira IA, Nobre LF, Neves FS. Computed tomography of pulmonary changes in rheumatoid arthritis: carcinoembryonic antigen (CEA) as a marker of airway disease. Rheumatol Int. 2016;36(4):531–9.
Pasteur MC, Helliwell SM, Houghton SJ, Webb SC, Foweraker JE, Coulden RA, et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1277–84.
Guan WJ, Gao YH, Xu G, Lin ZY, Tang Y, Li HM, et al. Aetiology of bronchiectasis in Guangzhou, southern China. Respirology (Carlton, Vic). 2015;20(5):739–48.
Bamji A, Cooke N. Rheumatoid arthritis and chronic bronchial suppuration. Scand J Rheumatol. 1985;14(1):15–21.
McMahon MJ, Swinson DR, Shettar S, Wolstenholme R, Chattopadhyay C, Smith P, et al. Bronchiectasis and rheumatoid arthritis: a clinical study. Ann Rheum Dis. 1993;52(11):776–9.
Shadick NA, Fanta CH, Weinblatt ME, O’Donnell W, Coblyn JS. Bronchiectasis. A late feature of severe rheumatoid arthritis. Medicine. 1994;73(3):161–70.
Despaux J, Polio JC, Toussirot E, Dalphin JC, Wendling D. Rheumatoid arthritis and bronchiectasis. A retrospective study of fourteen cases. Rev Rhum Engl Ed. 1996;63(11):801–8.
Allain J, Saraux A, Guedes C, Valls I, Devauchelle V, Le Goff P. Prevalence of symptomatic bronchiectasis in patients with rheumatoid arthritis. Rev Rhum Engl Ed. 1997;64(10):531–7.
Perry E, Eggleton P, De Soyza A, Hutchinson D, Kelly C. Increased disease activity, severity and autoantibody positivity in rheumatoid arthritis patients with co-existent bronchiectasis. Int J Rheum Dis 2015.
Puechal X, Genin E, Bienvenu T, Le Jeunne C, Dusser DJ. Poor survival in rheumatoid arthritis associated with bronchiectasis: a family-based cohort study. PLoS One. 2014;9(10):e110066. This study is one of the first to demonstrate that bronchiectasis in rheumatoid arthritis portends a very poor prognosis compared to patients without bronchiectasis.
Swinson DR, Symmons D, Suresh U, Jones M, Booth J. Decreased survival in patients with co-existent rheumatoid arthritis and bronchiectasis. Br J Rheumatol. 1997;36(6):689–91.
Geri G, Dadoun S, Bui T, Del Castillo PN, Paternotte S, Dougados M, et al. Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases. BMC Infect Dis. 2011;11:304.
Snowden N, Moran A, Booth J, Haeney MR, Swinson DR. Defective antibody production in patients with rheumatoid arthritis and bronchiectasis. Clin Rheumatol. 1999;18(2):132–5.
Puechal X, Bienvenu T, Genin E, Berthelot JM, Sibilia J, Gaudin P, et al. Mutations of the cystic fibrosis gene in patients with bronchiectasis associated with rheumatoid arthritis. Ann Rheum Dis. 2011;70(4):653–9.
Puechal X, Fajac I, Bienvenu T, Desmazes-Dufeu N, Hubert D, Kaplan JC, et al. Increased frequency of cystic fibrosis deltaF508 mutation in bronchiectasis associated with rheumatoid arthritis. Eur Respir J. 1999;13(6):1281–7.
Pillemer SR, Matteson EL, Jacobsson LT, Martens PB, Melton 3rd LJ, O’Fallon WM, et al. Incidence of physician-diagnosed primary Sjogren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc. 2001;76(6):593–9.
Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, et al. Epidemiology of primary Sjogren’s syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(11):1983–9.
Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand-Adam S. Pulmonary manifestations of Sjogren’s syndrome. Eur Respir Rev: Off J Eur Respir Soc. 2016;25(140):110–23.
Koyama M, Johkoh T, Honda O, Mihara N, Kozuka T, Tomiyama N, et al. Pulmonary involvement in primary Sjogren’s syndrome: spectrum of pulmonary abnormalities and computed tomography findings in 60 patients. J Thorac Imaging. 2001;16(4):290–6.
Uffmann M, Kiener HP, Bankier AA, Baldt MM, Zontsich T, Herold CJ. Lung manifestation in asymptomatic patients with primary Sjogren syndrome: assessment with high resolution CT and pulmonary function tests. J Thorac Imaging. 2001;16(4):282–9.
Lohrmann C, Uhl M, Warnatz K, Ghanem N, Kotter E, Schaefer O, et al. High-resolution CT imaging of the lung for patients with primary Sjogren’s syndrome. Eur J Radiol. 2004;52(2):137–43.
Soto-Cardenas MJ, Perez-De-Lis M, Bove A, Navarro C, Brito-Zeron P, Diaz-Lagares C, et al. Bronchiectasis in primary Sjogren’s syndrome: prevalence and clinical significance. Clin Exp Rheumatol. 2010;28(5):647–53.
Cassidy JT, Kennedy JD. Systemic lupus erythematosus presenting as bronchiectasis. Ir J Med Sci. 1961;422:65–9.
Clause HP, Sanger PW, Taylor FH, Robicsek F. Systemic lupus erythematosus associated with bronchiectasis: report of two cases. Dis chest. 1964;45:219–22.
Chisholm Jr JC. Bronchiectasis and systemic lupus erythematosus. J Natl Med Assoc. 1967;59(4):269–72.
Andonopoulos AP, Yarmenitis S, Georgiou P, Bounas A, Vlahanastasi C. Bronchiectasis in systemic sclerosis. A study using high resolution computed tomography. Clin Exp Rheumatol. 2001;19(2):187–90.
Hakim AJ, Sahota A. Joint hypermobility and skin elasticity: the hereditary disorders of connective tissue. Clin Dermatol. 2006;24(6):521–33.
Leung JM, Olivier KN, Prevots DR, McDonnell NB. Beyond Marfan: the clinical impact of bronchiectasis and non-tuberculous mycobacteria in connective tissue diseases. Int J Tuberc Lung Dis. 2015;19(11):1409.
Paulson ML, Olivier KN, Holland SM. Pulmonary non-tuberculous mycobacterial infection in congenital contractural arachnodactyly. Int J Tuberc Lung Dis. 2012;16(4):561–3.
Urban Z, Gao J, Pope FM, Davis EC. Autosomal dominant cutis laxa with severe lung disease: synthesis and matrix deposition of mutant tropoelastin. J Invest Dermatol. 2005;124(6):1193–9.
Marfan A. Un cas de déformation congénitale des quartre membres, plus prononcée aux extrémitiés, caractérisée par l’allongement des os avec un certain degré d’amincissement. Bull Mem Soc Med hop Paris. 1896;13:220–6.
Pepe G, Lapini I, Evangelisti L, Attanasio M, Giusti B, Lucarini L, et al. Is ectopia lentis in some cases a mild phenotypic expression of Marfan syndrome? Need for a long-term follow-up. Mol Vis. 2007;13:2242–7.
Gillis E, Kempers M, Salemink S, Timmermans J, Cheriex EC, Bekkers SC, et al. An FBN1 deep intronic mutation in a familial case of Marfan syndrome: an explanation for genetically unsolved cases? Hum Mutat. 2014;35(5):571–4.
Groth KA, Hove H, Kyhl K, Folkestad L, Gaustadnes M, Vejlstrup N, et al. Prevalence, incidence, and age at diagnosis in Marfan Syndrome. Orphanet J Rare Dis. 2015;10:153.
Lynas MA. Marfan’s syndrome in Northern Ireland; an account of thirteen families. Ann Hum Genet. 1958;22(4):289–309.
Sun QB, Zhang KZ, Cheng TO, Li SL, Lu BX, Zhang ZB, et al. Marfan syndrome in China: a collective review of 564 cases among 98 families. Am Heart J. 1990;120(4):934–48.
Gray JR, Bridges AB, Faed MJ, Pringle T, Baines P, Dean J, et al. Ascertainment and severity of Marfan syndrome in a Scottish population. J Med Genet. 1994;31(1):51–4.
Fuchs J. Marfan syndrome and other systemic disorders with congenital ectopia lentis. A Danish national survey. Acta Paediatr (Oslo, Norway: 1992). 1997;86(9):947–52.
Chiu HH, Wu MH, Chen HC, Kao FY, Huang SK. Epidemiological profile of Marfan syndrome in a general population: a national database study. Mayo Clin Proc. 2014;89(1):34–42.
Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352(6333):337–9.
Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet. 2003;33(3):407–11.
Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47(7):476–85.
Jondeau G, Detaint D, Tubach F, Arnoult F, Milleron O, Raoux F, et al. Aortic event rate in the Marfan population: a cohort study. Circulation. 2012;125(2):226–32.
Murdoch JL, Walker BA, Halpern BL, Kuzma JW, McKusick VA. Life expectancy and causes of death in the Marfan syndrome. N Engl J Med. 1972;286(15):804–8.
Milewicz DM, Dietz HC, Miller DC. Treatment of aortic disease in patients with Marfan syndrome. Circulation. 2005;111(11):e150–157.
Finkbohner R, Johnston D, Crawford ES, Coselli J, Milewicz DM. Marfan syndrome. Long-term survival and complications after aortic aneurysm repair. Circulation. 1995;91(3):728–33.
Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan’s syndrome. N Engl J Med. 1994;330(19):1335–41.
Silverman DI, Burton KJ, Gray J, Bosner MS, Kouchoukos NT, Roman MJ, et al. Life expectancy in the Marfan syndrome. Am J Cardiol. 1995;75(2):157–60.
Katz HL. Thoracic manifestation in Marfan’s syndrome (arachnodactyly). Q Bull Sea View Hosp N Y Sea View Hosp, Staten Island Clin Soc. 1952;13(2):95–106.
Teoh PC. Bronchiectasis and spontaneous pneumothorax in Marfan’s syndrome. Chest. 1977;72(5):672–3.
Foster ME, Foster DR. Bronchiectasis and Marfan’s syndrome. Postgrad Med J. 1980;56(660):718–9.
Gupta PP, Gupta KB, Gulia JS, Yadav R, Kumar S, Agarwal D. Apical pulmonary lesions due to Marfan syndrome misdiagnosed as pulmonary tuberculosis. N Z Med J. 2010;123(1318):67–72.
Wood JR, Bellamy D, Child AH, Citron KM. Pulmonary disease in patients with Marfan syndrome. Thorax. 1984;39(10):780–4.
Hwang HS, Yi CA, Yoo H, Yang JH, Kim DK, Koh WJ. The prevalence of bronchiectasis in patients with Marfan syndrome. Int J Tuberc lung Dis. 2014;18(8):995–7.
Mortani Barbosa Jr EJ, Pyeritz RE, Litt H, Desjardins B. Vascular Ehlers-Danlos syndrome presenting as rapidly progressive multiple arterial aneurysms and dissections. Am J Med Genet A. 2011;155a(12):3090–4.
Borck G, Beighton P, Wilhelm C, Kohlhase J, Kubisch C. Arterial rupture in classic Ehlers-Danlos syndrome with COL5A1 mutation. Am J Med Genet A. 2010;152a(8):2090–3.
Symoens S, Syx D, Malfait F, Callewaert B, De Backer J, Vanakker O, et al. Comprehensive molecular analysis demonstrates type V collagen mutations in over 90% of patients with classic EDS and allows to refine diagnostic criteria. Hum Mutat. 2012;33(10):1485–93.
Tsipouras P, Byers PH, Schwartz RC, Chu ML, Weil D, Pepe G, et al. Ehlers-Danlos syndrome type IV: cosegregation of the phenotype to a COL3A1 allele of type III procollagen. Hum Genet. 1986;74(1):41–6.
Mayer K, Kennerknecht I, Steinmann B. Clinical utility gene card for: Ehlers-Danlos syndrome types I-VII and variants - update 2012. Eur J Hum Genet: EJHG 2013: 21(1).
Mao JR, Bristow J. The Ehlers-Danlos syndrome: on beyond collagens. J Clin Invest. 2001;107(9):1063–9.
McDonnell NB, Gorman BL, Mandel KW, Schurman SH, Assanah-Carroll A, Mayer SA, et al. Echocardiographic findings in classical and hypermobile Ehlers-Danlos syndromes. Am J Med Genet A. 2006;140(2):129–36.
Bathen T, Hangmann AB, Hoff M, Andersen LO, Rand-Hendriksen S. Multidisciplinary treatment of disability in Ehlers-Danlos syndrome hypermobility type/hypermobility syndrome: a pilot study using a combination of physical and cognitive-behavioral therapy on 12 women. Am J Med Genet A. 2013;161a(12):3005–11.
Scheper MC, de Vries JE, Verbunt J, Engelbert RH. Chronic pain in hypermobility syndrome and Ehlers-Danlos syndrome (hypermobility type): it is a challenge. J Pain Res. 2015;8:591–601.
Robitaille GA. Ehlers-Danlos syndrome and recurrent hemoptysis. Ann Intern Med. 1964;61:716–21.
Al-Hajjaj MS. Bronchiectasis and mediastinal neurofibroma in a Saudi female with Ehlers-Danlos syndrome. Ann Saudi Med. 2000;20(5–6):419–20.
Iseman MD, Buschman DL, Ackerson LM. Pectus excavatum and scoliosis. Thoracic anomalies associated with pulmonary disease caused by Mycobacterium avium complex. Am Rev Respir Dis. 1991;144(4):914–6.
Kim RD, Greenberg DE, Ehrmantraut ME, Guide SV, Ding L, Shea Y, et al. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med. 2008;178(10):1066–74.
Kartalija M, Ovrutsky AR, Bryan CL, Pott GB, Fantuzzi G, Thomas J, et al. Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes. Am J Respir Crit Care Med. 2013;187(2):197–205.
Colombo RE, Hill SC, Claypool RJ, Holland SM, Olivier KN. Familial clustering of pulmonary nontuberculous mycobacterial disease. Chest. 2010;137(3):629–34.
Leung JM, Fowler C, Smith C, Adjemian J, Frein C, Claypool RJ, et al. A familial syndrome of pulmonary nontuberculous mycobacteria infections. Am J Respir Crit Care Med. 2013;188(11):1373–6.
Szymanski EP, Leung JM, Fowler CJ, Haney C, Hsu AP, Chen F, et al. Pulmonary nontuberculous mycobacterial infection. A multisystem, multigenic disease. Am J Respir Crit Care Med. 2015;192(5):618–28. This study uses whole exome sequencing to identify key connective tissue disease genes, mutations in which might contribute to the development of pulmonary nontuberculous mycobacteria infections.
Sibila O, Suarez-Cuartin G, Rodrigo-Troyano A, Fardon TC, Finch S, Mateus EF, et al. Secreted mucins and airway bacterial colonization in non-CF bronchiectasis. Respirology (Carlton, Vic). 2015;20(7):1082–8.
Vaahtovuo J, Munukka E, Korkeamaki M, Luukkainen R, Toivanen P. Fecal microbiota in early rheumatoid arthritis. J Rheumatol. 2008;35(8):1500–5.
Liu X, Zou Q, Zeng B, Fang Y, Wei H. Analysis of fecal Lactobacillus community structure in patients with early rheumatoid arthritis. Curr Microbiol. 2013;67(2):170–6.
Brusca SB, Abramson SB, Scher JU. Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity. Curr Opin Rheumatol. 2014;26(1):101–7.
Charlson ES, Bittinger K, Chen J, Diamond JM, Li H, Collman RG, et al. Assessing bacterial populations in the lung by replicate analysis of samples from the upper and lower respiratory tracts. PLoS One. 2012;7(9), e42786.
Scher JU, Ubeda C, Equinda M, Khanin R, Buischi Y, Viale A, et al. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum. 2012;64(10):3083–94.
Wegner N, Wait R, Sroka A, Eick S, Nguyen KA, Lundberg K, et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum. 2010;62(9):2662–72.
Taylor SL, Rogers GB, Chen AC, Burr LD, McGuckin MA, Serisier DJ. Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis. Ann Am Thorac Soc. 2015;12(5):701–7.
Ikonomidis JS, Jones JA, Barbour JR, Stroud RE, Clark LL, Kaplan BS, et al. Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome. Circulation. 2006;114(1 Suppl):I365–370.
Acknowledgments
This research was supported in part by the Intramural Research Program of the NIH, National Heart, Lung, and Blood Institute.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
Kenneth Olivier and Janice Leung declare no conflict of interest.
Human and animal rights and informed consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Bronchiectasis
Rights and permissions
About this article
Cite this article
Leung, J.M., Olivier, K.N. Bronchiectasis and connective tissue diseases. Curr Pulmonol Rep 5, 169–176 (2016). https://doi.org/10.1007/s13665-016-0154-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13665-016-0154-8